Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Paul D Bieniasz
Affiliation
The Rockefeller University
ORCID
Career Start Year
1993
Papers
247
H Index
86
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36646114
Molecular fate-mapping of serum antibody responses to repeat immunization.
Nature
2023
37625266
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV.
EBioMedicine
2023
38096415
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.
Proc Natl Acad Sci U S A
2023
37563124
SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates.
Nat Commun
2023
36952347
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain.
Cell Rep
2023
37425700
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
bioRxiv
2023
37188812
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies.
Nat Microbiol
2023
37341186
Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.
Biochemistry
2023
37368240
Memory B cell development elicited by mRNA booster vaccinations in the elderly.
J Exp Med
2023
36653360
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape.
Nat Commun
2023
36473496
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.
Nature
2023
36688533
Initiation of HIV-1 Gag lattice assembly is required for recognition of the viral genome packaging signal.
Elife
2023
35194607
Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose.
bioRxiv
2022
35776090
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans.
J Exp Med
2022
35735743
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.
mBio
2022
35796685
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants.
J Exp Med
2022
35636436
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis.
Lancet Microbe
2022
35665005
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
bioRxiv
2022
35818364
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.
Open Forum Infect Dis
2022
35358263
Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting.
PLoS One
2022
35447092
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.
Immunity
2022
35447027
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.
Nature
2022
36075961
Rational attenuation of RNA viruses with zinc finger antiviral protein.
Nat Microbiol
2022
36149398
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.
J Exp Med
2022
36136978
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
Proc Natl Acad Sci U S A
2022
36093344
Molecular fate-mapping of serum antibodies reveals the effects of antigenic imprinting on repeated immunization.
bioRxiv
2022
35982682
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination.
medRxiv
2022
36052368
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.
bioRxiv
2022
36006380
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.
J Exp Med
2022
35915556
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.
Gut Microbes
2022
35132412
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins.
bioRxiv
2022
35130321
Poly(ADP-ribose) potentiates ZAP antiviral activity.
PLoS Pathog
2022
35030645
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med
2022
35169812
Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population.
medRxiv
2022
35229640
VPS29 Exerts Opposing Effects on Endocytic Viral Entry.
mBio
2022
33173867
Evolution of Antibody Immunity to SARS-CoV-2.
bioRxiv
2021
33767445
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
Nature
2021
33851164
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
bioRxiv
2021
33567448
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Nature
2021
33901262
Origin and evolution of the zinc finger antiviral protein.
PLoS Pathog
2021
33758864
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.
bioRxiv
2021
33758856
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.
bioRxiv
2021
33503230
The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses.
Clin Infect Dis
2021
33501451
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
bioRxiv
2021
33501434
Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.
bioRxiv
2021
33688659
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants.
bioRxiv
2021
34936878
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
2021
34874007
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Elife
2021
34931199
Plasma neutralization properties of the SARS-CoV-2 Omicron variant.
medRxiv
2021
35262014
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.
J Clin Virol Plus
2021
1 - 50 of 247
Column Actions
Search
Recommended Authors
Hannah S Sperber
Institute for Translational HIV Research, University Hospital Essen
Career Start Year
2017
Number of shared co-authors
2
Simon Langer
University Hospital of Wurzburg
Career Start Year
2012
Number of shared co-authors
0
Jo??o I Mamede
Rush University Medical Center
Career Start Year
2011
Number of shared co-authors
0
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
7
Ferdinand Roesch
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year
2009
Number of shared co-authors
2
Blandine Monel
Institut Pasteur, CNRS UMR 3569
Career Start Year
2009
Number of shared co-authors
3
Kei Sato
The Institute of Medical Science, The University of Tokyo
Career Start Year
2008
Number of shared co-authors
0
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
7
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year
2007
Number of shared co-authors
2
Michael Nekorchuk
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
3
Charlotte A Stoneham
University of California
Career Start Year
2006
Number of shared co-authors
2
Mary K Lewinski
University of California
Career Start Year
2005
Number of shared co-authors
3
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year
2005
Number of shared co-authors
4
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year
2005
Number of shared co-authors
2
Felipe Diaz-Griffero
Albert Einstein College of Medicine
Career Start Year
2002
Number of shared co-authors
4
Priya S Shah
University of California davis
Career Start Year
2002
Number of shared co-authors
2
Clare Jolly
University College London
Career Start Year
2000
Number of shared co-authors
1
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year
2000
Number of shared co-authors
4
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year
1998
Number of shared co-authors
8
Abraham L Brass
University of Massachusetts Medical School
Career Start Year
1995
Number of shared co-authors
3
Vicente Planelles
University of Utah
Career Start Year
1991
Number of shared co-authors
4
Pavel Sova
Altius Institute for Biomedical Sciences
Career Start Year
1990
Number of shared co-authors
1
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year
1987
Number of shared co-authors
5
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year
1985
Number of shared co-authors
1
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year
1982
Number of shared co-authors
11
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year
1979
Number of shared co-authors
7
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year
1978
Number of shared co-authors
11
Wendy Maury
Carver College of Medicine, University of Iowa
Career Start Year
1978
Number of shared co-authors
0
John Guatelli
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year
1978
Number of shared co-authors
4
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Theodora Hatziioannou
The Rockefeller University
Co-authored papers
113
Fabian Schmidt
The Rockefeller University
Co-authored papers
54
Yiska Weisblum
Rockefeller University
Co-authored papers
30
Charles M Rice
Rockefeller University
Co-authored papers
22
Thiago Y Oliveira
The Rockefeller University
Co-authored papers
22
Pamela J Bjorkman
Co-authored papers
20
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers
13
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Co-authored papers
9
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers
9
Brandon F Keele
Co-authored papers
6
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Co-authored papers
5
George M Shaw
Co-authored papers
4
Beatrice H Hahn
Co-authored papers
4
Peter D Kwong
Co-authored papers
4
Greg J Towers
University College London
Co-authored papers
4
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers
4
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
4
Michael P Rout
The Rockefeller University
Co-authored papers
3
Michael S Seaman
Co-authored papers
3
Stephen P Goff
Columbia University
Co-authored papers
3
Jan Rozman
German Center for Diabetes Research (DZD)
Co-authored papers
3
Thomas J Ketas
Co-authored papers
3
Tongqing Zhou
Co-authored papers
3
Frederic Bibollet-Ruche
Co-authored papers
3
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
Natalia E Ketaren
The Rockefeller University
Co-authored papers
2
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Co-authored papers
2
Zandrea Ambrose
Co-authored papers
2
Celia C LaBranche
Co-authored papers
2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
1 - 30